Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis
- PMID: 29241771
- DOI: 10.1016/j.jaad.2017.04.1141
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis
Abstract
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. Significant variations in the clinical presentation of AA have been observed, ranging from small, well-circumscribed patches of hair loss to a complete absence of body and scalp hair. Patients affected by AA encompass all age groups, sexes, and ethnicities, and may experience frustration with the unpredictable nature of their disease for which there is currently no definitive treatment. The cause of AA remains incompletely understood, though it is believed to result-at least in part-from a loss of immune privilege in the hair follicle, autoimmune-mediated hair follicle destruction, and the upregulation of inflammatory pathways. Patients with AA frequently experience marked impairment in psychological well-being, self-esteem, and may be more likely to suffer from psychiatric comorbidities. Part one of this two-part continuing medical education series describes the epidemiology, clinical evaluation, prognosis, and recent advancements in the understanding of the pathogenesis of AA.
Keywords: alopecia areata; alopecia totalis; alopecia universalis; pathogenesis; prognosis; subtype.
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Alopecia areata.J Am Acad Dermatol. 2018 Jul;79(1):e9-e10. doi: 10.1016/j.jaad.2018.01.051. J Am Acad Dermatol. 2018. PMID: 29908825 No abstract available.
Similar articles
-
The autoimmune basis of alopecia areata: a comprehensive review.Autoimmun Rev. 2015 Feb;14(2):81-9. doi: 10.1016/j.autrev.2014.10.014. Epub 2014 Oct 12. Autoimmun Rev. 2015. PMID: 25315746 Review.
-
Alopecia areata: A multifactorial autoimmune condition.J Autoimmun. 2019 Mar;98:74-85. doi: 10.1016/j.jaut.2018.12.001. Epub 2018 Dec 15. J Autoimmun. 2019. PMID: 30558963 Review.
-
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.J Invest Dermatol. 2018 Jul;138(7):1539-1545. doi: 10.1016/j.jid.2018.01.032. Epub 2018 Feb 13. J Invest Dermatol. 2018. PMID: 29452121 Free PMC article. Clinical Trial.
-
Deciphering the Complex Immunopathogenesis of Alopecia Areata.Int J Mol Sci. 2024 May 22;25(11):5652. doi: 10.3390/ijms25115652. Int J Mol Sci. 2024. PMID: 38891839 Free PMC article. Review.
-
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):117-132. doi: 10.2174/1872213X14999200728145822. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 32723274 Review.
Cited by
-
Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report.Cureus. 2024 Oct 19;16(10):e71863. doi: 10.7759/cureus.71863. eCollection 2024 Oct. Cureus. 2024. PMID: 39559606 Free PMC article.
-
Mechanisms of autophagy and their implications in dermatological disorders.Front Immunol. 2024 Nov 4;15:1486627. doi: 10.3389/fimmu.2024.1486627. eCollection 2024. Front Immunol. 2024. PMID: 39559368 Free PMC article. Review.
-
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review.Thromb J. 2024 Nov 12;22(1):101. doi: 10.1186/s12959-024-00665-w. Thromb J. 2024. PMID: 39533305 Free PMC article. Review.
-
The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources.Acta Derm Venereol. 2024 Nov 7;104:adv41046. doi: 10.2340/actadv.v104.41046. Acta Derm Venereol. 2024. PMID: 39508499 Free PMC article.
-
Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe.Dermatol Ther (Heidelb). 2024 Dec;14(12):3243-3258. doi: 10.1007/s13555-024-01280-3. Epub 2024 Oct 16. Dermatol Ther (Heidelb). 2024. PMID: 39414726
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
